皮质类固醇在IgA脏病中与中度蛋白尿:一个回顾性队列研究
Yu Wang1,2,3, Jianwen Yu1,2, Yu Jiang1,2
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Nephrology (Carlton, Vic.)
|January 8, 2024
概括
皮质类固醇治疗可以改善IgA脏病 (IgAN) 患者的缓解率,这些患者有中度蛋白尿症. 虽然通常是安全的,但对功能终点的长期影响需要进一步研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮质类固醇是IgA脏病 (IgAN) 的一个有争议的治疗方法.
- 这项研究调查了IGAN患者中适度蛋白尿的皮质类固醇疗效和安全性.
研究的目的:
- 为了评估在IGAN患者中适度蛋白尿的皮质类固醇治疗的有效性.
- 在这个患者队列中评估皮质类固醇治疗的安全性.
主要方法:
- 在336名IgAN患者的回顾性队列研究中,EGFR>15mL/min/1.73m2和蛋白尿0.75-3.5g/d.
- 患者被分为皮质类固醇和支持性护理组.
- 倾向性得分匹配用于比较95对匹配对的结果.
主要成果:
- 与支持性护理相比,皮质类固醇治疗与更高的缓解率 (完全和部分缓解率) 相关,即使经过对混因素进行调整.
- 两组之间没有观察到严重不良事件的显著差异.
- 虽然缓解率较高,但该研究的短期随访限制了检测ESRD或死亡等长期终点差异的能力.
结论:
- 皮质类固醇治疗对IGAN患者具有中度蛋白尿的患者显示出潜在的益处.
- 益处包括增强蛋白尿减少和功能维护.
- 需要进一步的长期研究来证实对硬性临床结果的影响.
更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
120
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120
Inflammatory Bowel Disease IV: Pharmacological Management
128
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
128
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
Antihypertensive Drugs: Direct Renin Inhibitors
632
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
632
Drugs for Treatment of Ulcerative Colitis in IBD
144
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
144
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334


